Zobrazeno 1 - 10
of 114
pro vyhledávání: '"B. Tallman"'
Autor:
Caitlin M. McCracken, Kendall J. Tucker, Gregory B. Tallman, Haley K. Holmer, Brie N. Noble, Jessina C. McGregor
Publikováno v:
Antibiotics, Vol 12, Iss 4, p 672 (2023)
This study aimed to assess understanding of antibiotic resistance and evaluate antibiotic use themes among the general public. In March 2018, respondents that were ≥21 years old and residing in the United States were recruited from ResearchMatch.or
Externí odkaz:
https://doaj.org/article/9e36201cf49245c2bb27b9d94f6c4094
Autor:
Susan M. Mudambi, Stephen B. Tallman
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ae7dd680a5d5aa7dc5484fd5089bc1f
https://doi.org/10.2139/ssrn.4358760
https://doi.org/10.2139/ssrn.4358760
Autor:
Anupama Phene, Stephen B. Tallman
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a89448fdd0b76d740a3ae5bfb945071
https://doi.org/10.2139/ssrn.4360565
https://doi.org/10.2139/ssrn.4360565
Publikováno v:
Open Forum Infectious Diseases. 9
Background Dalbavancin is an intravenous (IV) long acting lipoglycopeptide approved for use in acute bacterial skin and skin structure infections (ABSSSI). However, given the prolonged half-life, there is interest in using this agent as an alternativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5806e8f5d184490466614f756d900261
https://doi.org/10.1093/ofid/ofac492.1458
https://doi.org/10.1093/ofid/ofac492.1458
Publikováno v:
Academy of Management Proceedings. 2022
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::334eba6e872838c715b22e8773aec255
https://doi.org/10.5465/ambpp.2022.13993symposium
https://doi.org/10.5465/ambpp.2022.13993symposium
Publikováno v:
Annals of Pharmacotherapy. 57:751-752
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f43a99605451361c463e9b918c237e
https://doi.org/10.1177/10600280221124510
https://doi.org/10.1177/10600280221124510
Autor:
Torben Petersen, Stephen B. Tallman
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb91c766d725a6231a6768226ce71a78
https://doi.org/10.2139/ssrn.4256512
https://doi.org/10.2139/ssrn.4256512
Autor:
Henry Arguinchona, Martin Fee, Philip Robinson, William R. Berrington, Ryan Roper, Reda Tipton, Glenn Doherty, Tyler J. Gluckman, Cameron J Cover, Brent Footer, Gregory B Tallman, George A Diaz, Jamie Mackiewicz, Steven M. Standaert, Paul A McKelvey, Delaney Goulet, Justin Rueda, Jose F Echaiz, Brittney C Ward, Jennifer Hadlock, Heather Algren, Shu-Ching Chang, Martha Dickinson Matson, Stephen Malkoski, Jodie Davila, Charles Laurenson, Mary Micikas, Jennifer E Marfori, Joshua Christensen, Ari Robicsek, Robert Choi, Charlotte Cronenweth, Alyssa B Christensen, Guilford T Parsons, Albert Pacifico, Gary L. Grunkemeier, Ekra Rai, Terese C Hammond, Daniel McClung, Tom French, Tobias Pusch, Yogavedya Mukkamala, Farjad Sarafian, Jason D Goldman
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 74(10)
Background The impact of remdesivir (RDV) on mortality rates in coronavirus disease 2019 (COVID-19) is controversial, and the mortality effect in subgroups of baseline disease severity has been incompletely explored. The purpose of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9979d2549e6c74d045372e54f3603d
https://pubmed.ncbi.nlm.nih.gov/34409431
https://pubmed.ncbi.nlm.nih.gov/34409431
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53941d4b978b71dae51e793ca0d3759c
https://doi.org/10.2139/ssrn.3930914
https://doi.org/10.2139/ssrn.3930914
Autor:
Ryan K. Shields, Gregory B Tallman, Yohei Doi, Roberta T. Mettus, Romney M. Humphries, Peera Hemarajata, Morgan Hakki, James S. Lewis
Publikováno v:
Clinical Infectious Diseases. 68:2045-2052
Background In Pseudomonas aeruginosa, fluoroquinolone exposure promotes resistance to carbapenems through upregulation of efflux pumps and transcriptional downregulation of the porin OprD. Evidence of this effect among hematologic malignancy (HM) pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df1b126d758ccfbc3a6f9b0b0162fd76
https://doi.org/10.1093/cid/ciy825
https://doi.org/10.1093/cid/ciy825